Zobrazeno 1 - 10
of 543
pro vyhledávání: '"Robert G Maki"'
Autor:
Robert G Maki, Joshua D Schiffman, Aleah F Caulin, Sophia Howard, Trent Fowler, Ivan Alferiev, Michael Chorny, Garrett Brodeur, Debra Thoma Vallner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0a5c65a82ee0481a8bb80c22b8e93eee
Autor:
Jonathan eNoujaim, Khin eThway, Zia eBajwa, Ayeza eBajwa, Robert G Maki, Robin Lewis Jones, Charles eKeller
Publikováno v:
Frontiers in Oncology, Vol 5 (2015)
Epithelioid sarcoma is a soft tissue sarcoma of children and young adults for which the preferred treatment for localised disease is wide surgical resection. Medical management is to a great extent undefined, and therefore for patients with regional
Externí odkaz:
https://doaj.org/article/0f1fd948ab644b768cdbfd57eb864daf
Autor:
Michael J Wagner, Robert G Maki
Publikováno v:
Frontiers in Oncology, Vol 3 (2013)
Data from over 20 years ago demonstrated potential use for IGF signaling modulators, specifically with IGF-1R antagonists, in a variety of pediatric and adolescent cancers, particularly in sarcomas. However, in spite of promising preclinical data, IG
Externí odkaz:
https://doaj.org/article/d69e63d3db604a5cb3f6747d70bef595
Publikováno v:
Future Oncology. 19:621-629
Dedifferentiated liposarcoma (DDLPS) is a rare, aggressive liposarcoma associated with poor prognosis. First-line treatment for advanced/metastatic DDLPS is systemic chemotherapy, but efficacy is poor and toxicities substantial. Most DDLPS tumors hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::601b2770cd2c576e7c2614e20134628a
https://doi.org/10.2217/fon-2022-1291
https://doi.org/10.2217/fon-2022-1291
Autor:
Vishruth K. Reddy, Varsha Jain, Robert J. Wilson II, Lee P. Hartner, Mark Diamond, Ronnie A. Sebro, Kristy L. Weber, Robert G. Maki, Jacob E. Shabason
Publikováno v:
Sarcoma, Vol 2021 (2021)
Purpose. Practice patterns for treatment of localized adult pleomorphic rhabdomyosarcoma (PRMS) remain quite variable given its rarity. Current national guidelines recommend management similar to that of other high-grade soft tissue sarcomas (STS), w
Externí odkaz:
https://doaj.org/article/012648b31e68495a81fa1dc2e81b23d3
Autor:
Amanda R. Dancsok, Dongxia Gao, Anna F. Lee, Sonja Eriksson Steigen, Jean-Yves Blay, David M. Thomas, Robert G. Maki, Torsten O. Nielsen, Elizabeth G. Demicco
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Early trials for immune checkpoint inhibitors in sarcomas have delivered mixed results, and efforts to improve outcomes now look to combinatorial strategies with novel immunotherapeutics, including some that target macrophages. To enhance our underst
Externí odkaz:
https://doaj.org/article/9e799c27028b46f5812c8bcc54b10c57
Autor:
Katherine A. Thornton, Elizabeth H. Baldini, Robert G. Maki, Brian O'Sullivan, Yan Leyfman, Chandrajit P. Raut
Publikováno v:
Holland‐Frei Cancer Medicine. :1-28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24120cc873e2dfbbb20a4f9aedbc63fb
https://doi.org/10.1002/9781119000822.hfcm113.pub2
https://doi.org/10.1002/9781119000822.hfcm113.pub2
Autor:
Gabriella N. Tortorello, Cimarron E. Sharon, Kevin L. Ma, Nikhita Perry, Jacob E. Shabason, Robert G. Maki, John T. Miura, Giorgos C. Karakousis
Publikováno v:
Journal of Surgical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb858f03976cffd2d919b7a9ff376d12
https://doi.org/10.1002/jso.27307
https://doi.org/10.1002/jso.27307
Autor:
Breelyn A. Wilky, Shreyaskumar Patel, Vinod Ravi, Jonathan C. Trent, Jonathan Cohen, Pasquale Benedetto, Robert G. Maki, Alexander J. Lazar, Andrew E. Rosenberg, Cristiam Moreno Tellez, Yupanqui Caldas, Jamie Sheren, Marta Braschi-Amirfarzan, Jyothi Jagannathan, Karan Malik, Katharina Feister, Kevin Sweet, Behrang Amini, Ty K. Subhawong, Angela Pang, Heath W. Catoe, Peter J. DeMaria, Robert Hsu, Neeta Somaiah, Ravin Ratan, Junxiao Hu, Michael J. Nathenson
Supplementary Data from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1660a371b227773d368d4c52d6dcc72a
https://doi.org/10.1158/1078-0432.22486985
https://doi.org/10.1158/1078-0432.22486985
Autor:
Breelyn A. Wilky, Shreyaskumar Patel, Vinod Ravi, Jonathan C. Trent, Jonathan Cohen, Pasquale Benedetto, Robert G. Maki, Alexander J. Lazar, Andrew E. Rosenberg, Cristiam Moreno Tellez, Yupanqui Caldas, Jamie Sheren, Marta Braschi-Amirfarzan, Jyothi Jagannathan, Karan Malik, Katharina Feister, Kevin Sweet, Behrang Amini, Ty K. Subhawong, Angela Pang, Heath W. Catoe, Peter J. DeMaria, Robert Hsu, Neeta Somaiah, Ravin Ratan, Junxiao Hu, Michael J. Nathenson
Purpose:Determine whether specific CTNNB1 or APC mutations in patients with desmoid tumor were associated with differences in clinical responses to systemic treatments.Experimental Design:We established a multi-institutional dataset of previously tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46ea4b558620bf4aabe4dceefc4277c0
https://doi.org/10.1158/1078-0432.c.6532433.v1
https://doi.org/10.1158/1078-0432.c.6532433.v1